World

Climate crisis one step ahead of us: Greek PM

Sep 01, 2023

Athens [Greece], September 1: The enormous scope of the wildfires that have struck Greece this summer can be attributed primarily to global warming, Prime Minister Kyriakos Mitsotakis told parliament in Athens on Thursday.
"The climate crisis is one step ahead of us," Mitsotakis said. The state structures currently in place would have increasing difficulty in combating the fires in the future, he added.
Mitsotakis said the fires had been preceded in July and August by the hottest, driest and windiest summer since recordings began. He paid tribute to firefighters sent from across the European Union to help douse the blazes.
Mitsotakis said that the authorities "and no one else" would investigate reports of arson. Referring to residents of the Evros region along the border with Turkey who blamed migrants for starting fires and acted against them, he said the government would not tolerate vigilantism.
"Our government will not tolerate self-appointed sheriffs," he said.
Mitsotakis pledged unbureaucratic assistance to people who had lost their homes, animals or businesses to the fires. And he defended decisions to evacuate villages and hotels. "People's lives have the highest priority for us," he said in reference to the evacuation of some 20,000 tourists on the island of Rhodes in July.
Fires continued burning for the 13th day in succession in the north-eastern region near the Turkish border.
Source: Qatar Tribune

More news

Concept Medical Announces Successful SIRONA Trial Results, Demonstrating Sirolimus-Coated Balloon as a Promising Alternative for PAD Treatment

Tampa (Florida) [US], January 7: Concept Medical Inc., a global leader in innovative drug-delivery technology, proudly reports positive outcomes from the SIRONA (Head-to-Head Comparison of SIROlimus versus Paclitaxel Drug-Eluting BallooNAngioplasty in the Femoropopliteal Artery) RCT, which show that its sirolimus-coated balloons (SCB) (MagicTouch -PTA) provide patency and functional benefits on par with paclitaxel-coated balloons for patients suffering from peripheral artery disease (PAD). The 1-year data was presented by Principal Investigator Prof. Ulf Teichgraber at the TCT USA 2024 conference in a Late-Breaking Clinical Trials Session (LBCT). Coverage by TCTMD has highlighted these findings, underscoring sirolimus-based therapy as a viable new option in femoropopliteal interventions.

Jan 07, 2025